Bio/Pharma News

Emergent BioSolutions Enters Agreement with ProMetic Life Sciences

May 19, 2015

Emergent gives ProMetic long-term access to its Winnipeg facility.

Alexion to Build Biologics Facility in Ireland

May 19, 2015

Alexion will construct a biologics facility in Ireland that is its first outside the US.

AstraZeneca Invests $285 Million in New Facility

May 18, 2015

AstraZeneca announces that it will invest $285 million in a new manufacturing facility in Sweden.

FDA Approves First Spray-Dried Biologic

May 15, 2015

Raplixa fibrin sealant, the first approved spray-dried biologic, is a hemostatic agent that helps control bleeding from small blood vessels during surgery.

FDA Advisory Panel Questions Clinical Meaningfulness of Vertex’s Cystic Fibrosis Drug Combo

May 13, 2015

FDA concludes Orkambi demonstrates a clinical benefit over placebo, but questions the magnitude of the improvement.

Eli Lilly Announces New Innovation Center

May 13, 2015

Eli Lilly announces that it will establish a drug delivery and device center in Cambridge, Massachusetts.

Juno Expands CAR T-cell Pipeline with $59 Million Acquisition

May 13, 2015

Juno Therapeutics announces that it will expand its cellular therapies pipeline with the acquisition of Stage Cell Therapeutics for €52.5 million.

Pfizer Acquires Minority Interest in AM-Pharma

May 13, 2015

Pfizer acquires minority equity stake in AM-Pharma and secures option to acquire remaining equity.

Baxter BioScience Expands Oncology Business

May 13, 2015

With acquisition of Oncaspar portfolio for leukemia from Sigma-Tau Finanziaria, Baxter BioScience adds an oncology infrastructure and biologic.

Novartis Announces EU Approval of Lung Cancer Drug

May 08, 2015

Novartis announces that its lung cancer drug, Zykadia, gained European Union approval.